BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 7060520)

  • 1. Dopaminergic modulation of aldosterone secretion in the rhesus monkey: evidence that dopamine affects the late pathway of aldosterone biosynthesis by inhibiting the conversion of corticosterone to 18-hydroxycorticosterone.
    Sowers JR; Berg G; Martin VS; Mayes DM
    Endocrinology; 1982 Apr; 110(4):1173-7. PubMed ID: 7060520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic modulation of 18-hydroxycorticosterone secretion in man.
    Sowers JR; Berg G; Tuck ML; Martin VI; Chandler DW; Mayes DM
    J Clin Endocrinol Metab; 1982 Mar; 54(3):523-7. PubMed ID: 7035483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of metoclopramide and domperidone on aldosterone, 18-hydroxycorticosterone and prolactin secretion in the rhesus monkey.
    Sowers JR; Eggena P; Phillips D
    Metabolism; 1982 Dec; 31(12):1219-23. PubMed ID: 7144566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of corticosteroid secretion by dopaminergic mechanisms in rhesus monkeys.
    Sowers JR
    Am J Physiol; 1982 Nov; 243(5):E375-9. PubMed ID: 7137342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic regulation of 18-hydroxycorticosterone and aldosterone secretion in man.
    Sowers JR; Beck FW
    Acta Endocrinol (Copenh); 1983 Feb; 102(2):258-64. PubMed ID: 6338674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for direct inhibitory effects of dopamine on zona glomerulosa secretion of 18-hydroxycorticosterone in rhesus monkeys.
    Sowers JR; Beck FW; Eggena P
    Life Sci; 1984 Jun; 34(24):2339-46. PubMed ID: 6727568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of metoclopramide and dopamine on mineralocorticoid secretion--in vivo and in vitro studies].
    Ojima M; Itoh N; Kusano Y; Yaginuma K; Fukuchi S
    Nihon Naibunpi Gakkai Zasshi; 1986 Mar; 62(3):197-207. PubMed ID: 3709883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of domperidone, an extracerebral inhibitor of dopamine receptors, on thyrotropin, prolactin, renin, aldosterone, and 18-hydroxycorticosterone secretion in man.
    Sowers JR; Sharp B; McCallum RW
    J Clin Endocrinol Metab; 1982 Apr; 54(4):869-71. PubMed ID: 7037817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of metoclopramide on plasma corticosteroid levels in sheep.
    Sowers JR; Beck FW; Stern N; Asp N
    Endocrinology; 1983 Sep; 113(3):903-6. PubMed ID: 6872958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopaminergic modulation of aldosterone secretion in the rat.
    Aguilera G; Catt KJ
    Endocrinology; 1984 Jan; 114(1):176-81. PubMed ID: 6317344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoid suppression enhances the 18-hydroxycorticosterone and aldosterone response to metoclopramide in man.
    Sowers JR; Beck FW; Stern N
    Life Sci; 1983 Dec; 33(25):2489-95. PubMed ID: 6645810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. Dissociation of responses to dopamine and bromocriptine.
    Carey RM; Thorner MO; Ortt EM
    J Clin Invest; 1980 Jul; 66(1):10-8. PubMed ID: 7400305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of metoclopramide and dopamine on plasma aldosterone concentration in normal man and rhesus monkeys (Macaca mulatta): a new model to study dopamine control of aldosterone secretion.
    Brown RD; Billman GE; Kem DC; Stone HL; Jiang NS; Kao P; Hegstad RL
    J Clin Endocrinol Metab; 1982 Nov; 55(5):828-32. PubMed ID: 7119085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ganglionic blockade with trimethaphan on corticosteroid responses to metoclopramide in rhesus monkeys.
    Sowers JR; Beck FW; Eggena P
    J Hypertens; 1984 Aug; 2(4):367-70. PubMed ID: 6152278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of renin activation and regulation of aldosterone and 18-hydroxycorticosterone biosynthesis in hyporeninemic hypoaldosteronism.
    Sowers JR; Beck FW; Waters BK; Barrett JD; Welch BG
    J Clin Endocrinol Metab; 1985 Jul; 61(1):60-7. PubMed ID: 2987296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metoclopramide, a dopamine antagonist, stimulates aldosterone secretion in rhesus monkeys but not in dogs or rabbits.
    Sowers JR; Sharp B; Levin ER; Golub MS; Eggena P
    Life Sci; 1981 Nov; 29(21):2171-5. PubMed ID: 7321755
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of upright posture on the aldosterone responses to dopamine, metoclopramide, angiotensin II, and adrenocorticotropin.
    Malchoff CD; Hughes JM; Carey RM
    J Clin Endocrinol Metab; 1987 Jul; 65(1):203-7. PubMed ID: 3034955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of metoclopramide on the secretion of aldosterone and other adrenocortical steroids.
    Nagahama S; Fujimaki M; Kawabe H; Nakamura R; Saito I; Saruta T
    Clin Endocrinol (Oxf); 1983 Mar; 18(3):287-93. PubMed ID: 6861367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine reduces aldosterone and 18-hydroxycorticosterone response to angiotensin II in patients with essential low-renin hypertension and idiopathic hyperaldosteronism.
    Witzgall H; Lorenz R; von Werder K; Weber PC
    Clin Sci (Lond); 1985 Mar; 68(3):291-9. PubMed ID: 3882312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of dopamine in the regulation of aldosterone and 18-hydroxycorticosterone secretion in man.
    Sowers JR; Beck FW
    J Endocrinol Invest; 1984 Oct; 7(5):473-9. PubMed ID: 6096435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.